BETA


2003/0093(CNS) Cancer screening

Progress: Procedure completed

RoleCommitteeRapporteurShadows
Lead ENVI MUSSA Antonio (icon: UEN UEN)
Former Committee Opinion ITRE
Former Committee Opinion FEMM JÖNS Karin (icon: PES PES)
Lead committee dossier:
Legal Basis:
EC Treaty (after Amsterdam) EC 152-p4

Events

2014/09/23
   EC - Follow-up document
Details

The Commission presents a report on the implementation of the Communication from the Commission on ‘ Action Against Cancer: European Partnership’ and on the Council Recommendation 2003/878/EC of 2 December 2003 on cancer screening.

To recall, the council Recommendation on cancer screening, unanimously adopted, acknowledges both the significance of the burden of cancer and the evidence for effectiveness of breast, cervical and colorectal cancer screening

The Recommendation calls on Member States to take common action to implement national population-based cancer screening programmes with appropriate quality assurance , in accordance with European best practice guidelines . It further invites the Commission to: (i) report on the implementation of cancer screening programmes, (ii) consider the extent to which the proposed measures are working effectively, and (iii) consider the need for further action. In 2008 a first implementation report on the Recommendation was published, covering the period 2003-2007 ( please see summary dated 22/12/2008. )

The report summarises the main achievements in the fight against cancer in the EU in the framework of both initiatives towards the target to reduce cancer incidence by 15% by 2020.

Main results :

· Political will : the vast majority of Member States – 24 out of 28 - met the target of producing a National Cancer Control Plan (NCCP) before 2013.

· Support for Member States : through a Joint Action under the Health programme, guidance for Member States on establishing national cancer plans and on cancer care has been developed. A new Joint Action launched in 2014 will lead to a European Guide on Quality Improvement in Comprehensive Cancer Control. The Directive on the application of patients’ rights in cross-border healthcare provides further opportunities for increased cooperation through European Reference Networks between healthcare providers and centres of expertise.

· Prevention: the fourth version of the European Code Against Cancer supported by the Commission through administrative agreements with the International Agency for Research on Cancer will be launched soon.

· Screening: based on current projections, well over 500 million screening examinations for breast, cervical and/or colorectal cancer will have been performed in publicly mandated programmes in the EU between 2010 and 2020. European Guidelines for quality assurance in screening and diagnosis have been produced for breast cancer (2006, supplements 2013), cervical cancer (2008, second edition 2014) and colorectal cancer (2010).

· Quality assurance : the Commission is developing a Quality Assurance scheme for Breast Cancer Services based on the European legislative framework.

· Research: during the last seven years, the EU has invested more than EUR 1.4 billion in research efforts in relation to cancer. More than half of this budget – EUR 770 million – has been invested in collaborative research projects to find new ways of fighting cancer and supporting patients.

· Cancer information : in 2012, the Joint Research Centre was made responsible for coordinating the European Cancer Information System and acting as repository of European Union data and tools.

· Coordination: to improve the coordination of the range of cancer initiatives at EU level, the Commission established a European Union Group of Experts on Cancer Control in 2014.

Next steps : EU action on cancer based on the Commission Communication has strengthened cooperation between the European Union, Member States and relevant stakeholders and has created European added value in relevant areas (NCCP, screening, cancer information system, rare cancers, etc.) as well as a practical basis on which to continue and expand mechanisms for cooperation.

This cooperation in strategic areas provided a framework which made a sustainable contribution to reduce the burden of cancer in the EU and towards maintaining the target of a 15% reduction by 2020. According to the last available data, in the period 2000-2010, the incidence of the most frequently occurring forms of cancers (i.e. breast, lung, prostate and colorectal) decreased by about 10%.

In order to take forward this cooperation, the Commission sets out some of the next steps:

- the 3rd EU Health Programme offers opportunities to promote public health action on cancer and Horizon 2020 , in particular its Health, demographic change and wellbeing objective, offers opportunities to pursue research on cancer and other major chronic diseases.

- continued support for the development of high quality National Cancer Plans in the European Union;

- the new Tobacco Products Directive which should be fully operational by ensuring full use of its delegated and implementing powers as well as supporting its implementation by Member States in order to reduce smoking throughout the EU and contributing to reduce the incidence of cancer;

- enhance cooperation between the fields of Public Health, Environment and Occupational Health in order to tackle the avoidable causes of cancer from a broader perspective;

supporting a voluntary European Quality Assurance scheme for breast cancer services;

- creation of European Reference Networks, including on rare tumours. The Commission intends to organise calls for Networks in 2014 and 2015;

improving screening programmes and networking between centres and experts, at the EU, national and regional level;

- consideration of a specific Action on Rare Cancers;

- wider uptake of eHealth for efficient disease management and to strengthen effective prevention practices.

The recommendations of Members States and stakeholders, in the framework of the Commission Group of Experts on Cancer Control, will also be taken into account.

The report states that the Commission maintains the objective of reducing the burden of cancer in the EU, and the target of a 15% reduction of cancer incidence by 2020 ( 510,000 new cases ).

2008/12/22
   EC - Follow-up document
Details

This report examines the implementation of Council Recommendation 2003/878/EC of 2 December 2003 on cancer screening programmes. Recall that the Recommendation spells out fundamental principles of best practice in early detection of cancer and invites Member States to take common action to implement national cancer screening programmes with a population-based approach and with appropriate quality assurance at all levels, taking into account European Quality Assurance Guidelines for Cancer Screening, where they exist. Updated and expanded EU guidelines for breast and cervical cancer screening have recently been published by the Commission; comprehensive European guidelines for quality assurance of colorectal cancer screening are currently in preparation.

Moreover, the Recommendation invites the European Commission to report on the implementation of cancer screening programmes, to consider the extent to which the proposed measures are working effectively, and to consider the need for further action. This is the first such report.

Main findings : after circulatory disease, cancer is the second most common cause of death in the European Union in 2006, accounting for two out of ten deaths in women, which amounts to a total number of 554 000 women, and three out of ten deaths in men, which amounts to 698 000 men. Due to the ageing population this number is expected to rise further every year, if no preventive action is taken by the EC and the Member States.

As regards cancer cases, every year, 3.2 million Europeans are diagnosed with cancer, most of whom are suffering from breast, colorectal or lung cancers. However, the burden of cancer is far from being equally distributed across the European Union. Breast, cervical and colorectal cancer are a major cause of suffering and death in the Member States of the European Union. According to estimates of incidence and mortality by the International Agency for Research on Cancer (IARC), there were 331 000 new cases and 90 000 deaths due to breast cancer, and 36 500 new cases and 15 000 deaths due to cervical cancer among women in the EU in 2006. At the same time, new cases of colorectal cancer were estimated at 140 000 in women and 170 000 in men. Colorectal cancer deaths were estimated at 68 000 for women and 78 000 for men in the EU. Together, these cancers account for almost one out of two (47%) new cases and one out of three (32%) cancer deaths in women in the EU . In men, colorectal cancer currently accounts for one out of eight (13%) new cases and one out of nine (11%) cancer deaths.

Main conclusions : four years after the adoption of a Recommendation on Cancer Screening, most Member States have acted on the Recommendation and intend to undertake further action where implementation is not yet complete. Thus, the formulation of joint priorities and principles of health policy at the European level has been followed up by actions at the level of the Member States to implement the shared policies and priorities.

Nevertheless, and despite these substantial efforts, overall the EU is still only around half-way towards implementing the Recommendation. Slightly less than half the population who should be covered by screening according to the Recommendation actually are and less than half of those examinations are performed as part of screening programmes meeting the stipulations of the Recommendation. This illustrates the need for greater efforts within Member States , supported by collaboration between Member States and professional, organisational and scientific support. Substantial added value may be expected from such support and from additional efforts to improve and maintain high quality of screening programmes.

Even though the current volume of activities is still far from the level which can be expected in the future, the current expenditure in human and financial resources is already considerable. A sustained effort is therefore necessary at Community level and within Member States in identifying appropriate and effective measures to assure the quality, effectiveness and cost-effectiveness of current and future screening activities, taking into account scientific developments. Regular, systematic investigation, monitoring, evaluation and EU-wide status reporting on implementation of cancer screening programmes will continue to support exchange of information on successful developments and to identify weak points requiring improvement.

Cancer continues to represent one of the greatest burdens of ill-health within the European Union. The Recommendation on cancer screening represents a shared EU-wide commitment to taking practical steps to minimise that burden in practice, to the benefit of individual citizens and their families as well as to society as a whole. Actions to better monitor and prevent cancer at Community and Member States’ level can help to reduce the number of cases arising at all. Application of best-practice treatment can help to ensure better outcomes for people with cancer, as can European cooperation on cancer research for the future.

In 2009 the Commission intends to launch a partnership for action against cancer. This partnership intends to put in place EU-wide commitments on concrete action to prevent and control cancer and thus contribute to reducing inequalities in tackling cancer. It will aim to support the Member States by providing a framework for identifying and sharing information, capacity and expertise in cancer prevention and control, and by engaging relevant stakeholders across the European Union in a collective effort to reduce the burden of ill health that cancer represents.

2003/12/16
   Final act published in Official Journal
2003/12/02
   EP/CSL - Act adopted by Council after consultation of Parliament
2003/12/02
   EP - End of procedure in Parliament
2003/12/01
   CSL - Resolution/conclusions adopted by Council
2003/12/01
   CSL - Council Meeting
2003/11/19
   EP - Text adopted by Parliament, 1st reading/single reading
2003/11/19
   EP - Decision by Parliament
Documents
2003/11/18
   EP - Debate in Parliament
2003/11/04
   EP - Committee report tabled for plenary, 1st reading/single reading
Documents
2003/11/04
   EP - Vote in committee
2003/11/03
   EP - Committee report tabled for plenary, 1st reading/single reading
Documents
2003/09/01
   EP - Committee referral announced in Parliament
2003/07/08
   EP - MUSSA Antonio (UEN) appointed as rapporteur in ENVI
2003/05/20
   EP - JÖNS Karin (PES) appointed as rapporteur in FEMM
2003/05/05
   EC - Legislative proposal
2003/05/04
   EC - Legislative proposal published

Documents

  • Follow-up document: COM(2014)0584
  • Follow-up document: EUR-Lex
  • Follow-up document: COM(2008)0882
  • Follow-up document: EUR-Lex
  • Text adopted by Parliament, 1st reading/single reading: T5-0502/2003
  • Text adopted by Parliament, 1st reading/single reading: OJ C 087 07.04.2004, p. 0074-0263 E
  • Decision by Parliament: T5-0502/2003
  • Debate in Parliament: Debate in Parliament
  • Committee report tabled for plenary, 1st reading/single reading: A5-0381/2003
  • Committee report tabled for plenary, 1st reading/single reading: A5-0381/2003
  • Legislative proposal: EUR-Lex
  • Legislative proposal: COM(2003)0230
  • Legislative proposal published: EUR-Lex
  • Legislative proposal published: COM(2003)0230
  • Legislative proposal: EUR-Lex COM(2003)0230
  • Committee report tabled for plenary, 1st reading/single reading: A5-0381/2003
  • Text adopted by Parliament, 1st reading/single reading: T5-0502/2003 OJ C 087 07.04.2004, p. 0074-0263 E
  • Follow-up document: COM(2008)0882 EUR-Lex
  • Follow-up document: COM(2014)0584 EUR-Lex

History

(these mark the time of scraping, not the official date of the change)

docs/0
date
2003-05-05T00:00:00
docs
summary
type
Legislative proposal
body
EC
docs/0
date
2003-09-25T00:00:00
docs
title: PE331.672
type
Committee draft report
body
EP
docs/1
date
2003-10-09T00:00:00
docs
title: PE331.577/DEF
committee
FEMM
type
Committee opinion
body
EP
docs/2
date
2003-10-22T00:00:00
docs
title: PE331.672/AM
type
Amendments tabled in committee
body
EP
docs/4
date
2014-09-23T00:00:00
docs
summary
type
Follow-up document
body
EC
docs/4/docs/0/url
Old
http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2014/0584/COM_COM(2014)0584_EN.pdf
New
http://www.europarl.europa.eu/registre/docs_autres_institutions/commission_europeenne/com/2014/0584/COM_COM(2014)0584_EN.pdf
docs/6
date
2014-09-23T00:00:00
docs
summary
type
Follow-up document
body
EC
events/0/date
Old
2003-05-05T00:00:00
New
2003-05-04T00:00:00
events/3/date
Old
2003-11-04T00:00:00
New
2003-11-03T00:00:00
procedure/final/url
Old
https://eur-lex.europa.eu/JOHtml.do?uri=OJ:L:2003:327:SOM:EN:HTML
New
https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L:2003:327:TOC
docs/3/docs/0/url
Old
http://www.europarl.europa.eu/doceo/document/A-5-2003-0381_EN.html
New
https://www.europarl.europa.eu/doceo/document/A-5-2003-0381_EN.html
docs/4/docs/0/url
Old
http://www.europarl.europa.eu/doceo/document/TA-5-2003-0502_EN.html
New
https://www.europarl.europa.eu/doceo/document/TA-5-2003-0502_EN.html
docs/5/docs/0/url
Old
http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2008/0882/COM_COM(2008)0882_EN.pdf
New
http://www.europarl.europa.eu/registre/docs_autres_institutions/commission_europeenne/com/2008/0882/COM_COM(2008)0882_EN.pdf
docs/6/docs/0/url
Old
http://www.europarl.europa.eu/registre/docs_autres_institutions/commission_europeenne/com/2014/0584/COM_COM(2014)0584_EN.pdf
New
http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2014/0584/COM_COM(2014)0584_EN.pdf
events/1/type
Old
Committee referral announced in Parliament, 1st reading/single reading
New
Committee referral announced in Parliament
events/2/type
Old
Vote in committee, 1st reading/single reading
New
Vote in committee
events/3/docs/0/url
Old
http://www.europarl.europa.eu/doceo/document/A-5-2003-0381_EN.html
New
https://www.europarl.europa.eu/doceo/document/A-5-2003-0381_EN.html
events/4/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?secondRef=TOC&language=EN&reference=20031118&type=CRE
New
https://www.europarl.europa.eu/doceo/document/EN&reference=20031118&type=CRE
events/5
date
2003-11-19T00:00:00
type
Decision by Parliament
body
EP
docs
url: https://www.europarl.europa.eu/doceo/document/TA-5-2003-0502_EN.html title: T5-0502/2003
summary
events/5
date
2003-11-19T00:00:00
type
Decision by Parliament, 1st reading/single reading
body
EP
docs
url: http://www.europarl.europa.eu/doceo/document/TA-5-2003-0502_EN.html title: T5-0502/2003
summary
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Environment, Public Health, Consumer Policy
committee
ENVI
rapporteur
name: MUSSA Antonio date: 2003-07-08T00:00:00 group: Union for Europe of the Nations abbr: UEN
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Environment, Public Health, Consumer Policy
committee
ENVI
date
2003-07-08T00:00:00
rapporteur
name: MUSSA Antonio group: Union for Europe of the Nations abbr: UEN
committees/1/date
    committees/2
    type
    Former Committee Opinion
    body
    EP
    associated
    False
    committee_full
    Women's Rights and Equal Opportunities
    committee
    FEMM
    rapporteur
    name: JÖNS Karin date: 2003-05-20T00:00:00 group: Party of European Socialists abbr: PES
    committees/2
    type
    Former Committee Opinion
    body
    EP
    associated
    False
    committee_full
    Women's Rights and Equal Opportunities
    committee
    FEMM
    date
    2003-05-20T00:00:00
    rapporteur
    name: JÖNS Karin group: Party of European Socialists abbr: PES
    docs/3/docs/0/url
    Old
    http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A5-2003-381&language=EN
    New
    http://www.europarl.europa.eu/doceo/document/A-5-2003-0381_EN.html
    docs/4/docs/0/url
    Old
    http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P5-TA-2003-502
    New
    http://www.europarl.europa.eu/doceo/document/TA-5-2003-0502_EN.html
    docs/6/docs/0/url
    Old
    http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2014/0584/COM_COM(2014)0584_EN.pdf
    New
    http://www.europarl.europa.eu/registre/docs_autres_institutions/commission_europeenne/com/2014/0584/COM_COM(2014)0584_EN.pdf
    events/3/docs/0/url
    Old
    http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A5-2003-381&language=EN
    New
    http://www.europarl.europa.eu/doceo/document/A-5-2003-0381_EN.html
    events/5/docs/0/url
    Old
    http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P5-TA-2003-502
    New
    http://www.europarl.europa.eu/doceo/document/TA-5-2003-0502_EN.html
    procedure/final/url
    Old
    https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L:2003:327:TOC
    New
    https://eur-lex.europa.eu/JOHtml.do?uri=OJ:L:2003:327:SOM:EN:HTML
    activities
    • date: 2003-05-05T00:00:00 docs: url: http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2003&nu_doc=230 title: COM(2003)0230 type: Legislative proposal published celexid: CELEX:52003PC0230:EN body: EC commission: DG: Development type: Legislative proposal published
    • date: 2003-09-01T00:00:00 body: EP type: Committee referral announced in Parliament, 1st reading/single reading committees: body: EP responsible: True committee: ENVI date: 2003-07-08T00:00:00 committee_full: Environment, Public Health, Consumer Policy rapporteur: group: UEN name: MUSSA Antonio body: EP responsible: False committee: FEMM date: 2003-05-20T00:00:00 committee_full: Women's Rights and Equal Opportunities rapporteur: group: PSE name: JÖNS Karin body: EP responsible: False committee_full: Industry, External Trade, Research, Energy committee: ITRE
    • body: EP committees: body: EP responsible: True committee: ENVI date: 2003-07-08T00:00:00 committee_full: Environment, Public Health, Consumer Policy rapporteur: group: UEN name: MUSSA Antonio body: EP responsible: False committee: FEMM date: 2003-05-20T00:00:00 committee_full: Women's Rights and Equal Opportunities rapporteur: group: PSE name: JÖNS Karin body: EP responsible: False committee_full: Industry, External Trade, Research, Energy committee: ITRE docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A5-2003-381&language=EN type: Committee report tabled for plenary, 1st reading/single reading title: A5-0381/2003 date: 2003-11-04T00:00:00 type: Vote in committee, 1st reading/single reading
    • date: 2003-11-18T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?secondRef=TOC&language=EN&reference=20031118&type=CRE type: Debate in Parliament title: Debate in Parliament body: EP type: Debate in Parliament
    • date: 2003-11-19T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P5-TA-2003-502 type: Decision by Parliament, 1st reading/single reading title: T5-0502/2003 body: EP type: Decision by Parliament, 1st reading/single reading
    • date: 2003-12-01T00:00:00 body: CSL type: Council Meeting council: Employment, Social Policy, Health and Consumer Affairs meeting_id: 2549
    • date: 2003-12-02T00:00:00 body: EP type: End of procedure in Parliament
    • date: 2003-12-02T00:00:00 body: EP/CSL type: Act adopted by Council after consultation of Parliament
    • date: 2003-12-16T00:00:00 type: Final act published in Official Journal
    commission
    • body: EC dg: Development commissioner: --
    committees/0
    type
    Responsible Committee
    body
    EP
    associated
    False
    committee_full
    Environment, Public Health, Consumer Policy
    committee
    ENVI
    date
    2003-07-08T00:00:00
    rapporteur
    name: MUSSA Antonio group: Union for Europe of the Nations abbr: UEN
    committees/0
    body
    EP
    responsible
    True
    committee
    ENVI
    date
    2003-07-08T00:00:00
    committee_full
    Environment, Public Health, Consumer Policy
    rapporteur
    group: UEN name: MUSSA Antonio
    committees/1
    type
    Former Committee Opinion
    body
    EP
    associated
    False
    committee_full
    Industry, External Trade, Research, Energy
    committee
    ITRE
    date
    committees/1
    body
    EP
    responsible
    False
    committee
    FEMM
    date
    2003-05-20T00:00:00
    committee_full
    Women's Rights and Equal Opportunities
    rapporteur
    group: PSE name: JÖNS Karin
    committees/2
    type
    Former Committee Opinion
    body
    EP
    associated
    False
    committee_full
    Women's Rights and Equal Opportunities
    committee
    FEMM
    date
    2003-05-20T00:00:00
    rapporteur
    name: JÖNS Karin group: Party of European Socialists abbr: PES
    committees/2
    body
    EP
    responsible
    False
    committee_full
    Industry, External Trade, Research, Energy
    committee
    ITRE
    council
    • body: CSL type: Council Meeting council: Employment, Social Policy, Health and Consumer Affairs meeting_id: 2549 url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=SMPL&ROWSPP=25&RESULTSET=1&NRROWS=500&DOC_LANCD=EN&ORDERBY=DOC_DATE+DESC&CONTENTS=2549*&MEET_DATE=01/12/2003 date: 2003-12-01T00:00:00
    docs
    • date: 2003-09-25T00:00:00 docs: title: PE331.672 type: Committee draft report body: EP
    • date: 2003-10-09T00:00:00 docs: title: PE331.577/DEF committee: FEMM type: Committee opinion body: EP
    • date: 2003-10-22T00:00:00 docs: title: PE331.672/AM type: Amendments tabled in committee body: EP
    • date: 2003-11-04T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A5-2003-381&language=EN title: A5-0381/2003 type: Committee report tabled for plenary, 1st reading/single reading body: EP
    • date: 2003-11-19T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P5-TA-2003-502 title: T5-0502/2003 title: OJ C 087 07.04.2004, p. 0074-0263 E summary: type: Text adopted by Parliament, 1st reading/single reading body: EP
    • date: 2008-12-22T00:00:00 docs: url: http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2008/0882/COM_COM(2008)0882_EN.pdf title: COM(2008)0882 url: https://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2008&nu_doc=882 title: EUR-Lex summary: This report examines the implementation of Council Recommendation 2003/878/EC of 2 December 2003 on cancer screening programmes. Recall that the Recommendation spells out fundamental principles of best practice in early detection of cancer and invites Member States to take common action to implement national cancer screening programmes with a population-based approach and with appropriate quality assurance at all levels, taking into account European Quality Assurance Guidelines for Cancer Screening, where they exist. Updated and expanded EU guidelines for breast and cervical cancer screening have recently been published by the Commission; comprehensive European guidelines for quality assurance of colorectal cancer screening are currently in preparation. Moreover, the Recommendation invites the European Commission to report on the implementation of cancer screening programmes, to consider the extent to which the proposed measures are working effectively, and to consider the need for further action. This is the first such report. Main findings : after circulatory disease, cancer is the second most common cause of death in the European Union in 2006, accounting for two out of ten deaths in women, which amounts to a total number of 554 000 women, and three out of ten deaths in men, which amounts to 698 000 men. Due to the ageing population this number is expected to rise further every year, if no preventive action is taken by the EC and the Member States. As regards cancer cases, every year, 3.2 million Europeans are diagnosed with cancer, most of whom are suffering from breast, colorectal or lung cancers. However, the burden of cancer is far from being equally distributed across the European Union. Breast, cervical and colorectal cancer are a major cause of suffering and death in the Member States of the European Union. According to estimates of incidence and mortality by the International Agency for Research on Cancer (IARC), there were 331 000 new cases and 90 000 deaths due to breast cancer, and 36 500 new cases and 15 000 deaths due to cervical cancer among women in the EU in 2006. At the same time, new cases of colorectal cancer were estimated at 140 000 in women and 170 000 in men. Colorectal cancer deaths were estimated at 68 000 for women and 78 000 for men in the EU. Together, these cancers account for almost one out of two (47%) new cases and one out of three (32%) cancer deaths in women in the EU . In men, colorectal cancer currently accounts for one out of eight (13%) new cases and one out of nine (11%) cancer deaths. Main conclusions : four years after the adoption of a Recommendation on Cancer Screening, most Member States have acted on the Recommendation and intend to undertake further action where implementation is not yet complete. Thus, the formulation of joint priorities and principles of health policy at the European level has been followed up by actions at the level of the Member States to implement the shared policies and priorities. Nevertheless, and despite these substantial efforts, overall the EU is still only around half-way towards implementing the Recommendation. Slightly less than half the population who should be covered by screening according to the Recommendation actually are and less than half of those examinations are performed as part of screening programmes meeting the stipulations of the Recommendation. This illustrates the need for greater efforts within Member States , supported by collaboration between Member States and professional, organisational and scientific support. Substantial added value may be expected from such support and from additional efforts to improve and maintain high quality of screening programmes. Even though the current volume of activities is still far from the level which can be expected in the future, the current expenditure in human and financial resources is already considerable. A sustained effort is therefore necessary at Community level and within Member States in identifying appropriate and effective measures to assure the quality, effectiveness and cost-effectiveness of current and future screening activities, taking into account scientific developments. Regular, systematic investigation, monitoring, evaluation and EU-wide status reporting on implementation of cancer screening programmes will continue to support exchange of information on successful developments and to identify weak points requiring improvement. Cancer continues to represent one of the greatest burdens of ill-health within the European Union. The Recommendation on cancer screening represents a shared EU-wide commitment to taking practical steps to minimise that burden in practice, to the benefit of individual citizens and their families as well as to society as a whole. Actions to better monitor and prevent cancer at Community and Member States’ level can help to reduce the number of cases arising at all. Application of best-practice treatment can help to ensure better outcomes for people with cancer, as can European cooperation on cancer research for the future. In 2009 the Commission intends to launch a partnership for action against cancer. This partnership intends to put in place EU-wide commitments on concrete action to prevent and control cancer and thus contribute to reducing inequalities in tackling cancer. It will aim to support the Member States by providing a framework for identifying and sharing information, capacity and expertise in cancer prevention and control, and by engaging relevant stakeholders across the European Union in a collective effort to reduce the burden of ill health that cancer represents. type: Follow-up document body: EC
    • date: 2014-09-23T00:00:00 docs: url: http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2014/0584/COM_COM(2014)0584_EN.pdf title: COM(2014)0584 url: https://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2014&nu_doc=0584 title: EUR-Lex summary: The Commission presents a report on the implementation of the Communication from the Commission on ‘ Action Against Cancer: European Partnership’ and on the Council Recommendation 2003/878/EC of 2 December 2003 on cancer screening. To recall, the council Recommendation on cancer screening, unanimously adopted, acknowledges both the significance of the burden of cancer and the evidence for effectiveness of breast, cervical and colorectal cancer screening The Recommendation calls on Member States to take common action to implement national population-based cancer screening programmes with appropriate quality assurance , in accordance with European best practice guidelines . It further invites the Commission to: (i) report on the implementation of cancer screening programmes, (ii) consider the extent to which the proposed measures are working effectively, and (iii) consider the need for further action. In 2008 a first implementation report on the Recommendation was published, covering the period 2003-2007 ( please see summary dated 22/12/2008. ) The report summarises the main achievements in the fight against cancer in the EU in the framework of both initiatives towards the target to reduce cancer incidence by 15% by 2020. Main results : · Political will : the vast majority of Member States – 24 out of 28 - met the target of producing a National Cancer Control Plan (NCCP) before 2013. · Support for Member States : through a Joint Action under the Health programme, guidance for Member States on establishing national cancer plans and on cancer care has been developed. A new Joint Action launched in 2014 will lead to a European Guide on Quality Improvement in Comprehensive Cancer Control. The Directive on the application of patients’ rights in cross-border healthcare provides further opportunities for increased cooperation through European Reference Networks between healthcare providers and centres of expertise. · Prevention: the fourth version of the European Code Against Cancer supported by the Commission through administrative agreements with the International Agency for Research on Cancer will be launched soon. · Screening: based on current projections, well over 500 million screening examinations for breast, cervical and/or colorectal cancer will have been performed in publicly mandated programmes in the EU between 2010 and 2020. European Guidelines for quality assurance in screening and diagnosis have been produced for breast cancer (2006, supplements 2013), cervical cancer (2008, second edition 2014) and colorectal cancer (2010). · Quality assurance : the Commission is developing a Quality Assurance scheme for Breast Cancer Services based on the European legislative framework. · Research: during the last seven years, the EU has invested more than EUR 1.4 billion in research efforts in relation to cancer. More than half of this budget – EUR 770 million – has been invested in collaborative research projects to find new ways of fighting cancer and supporting patients. · Cancer information : in 2012, the Joint Research Centre was made responsible for coordinating the European Cancer Information System and acting as repository of European Union data and tools. · Coordination: to improve the coordination of the range of cancer initiatives at EU level, the Commission established a European Union Group of Experts on Cancer Control in 2014. Next steps : EU action on cancer based on the Commission Communication has strengthened cooperation between the European Union, Member States and relevant stakeholders and has created European added value in relevant areas (NCCP, screening, cancer information system, rare cancers, etc.) as well as a practical basis on which to continue and expand mechanisms for cooperation. This cooperation in strategic areas provided a framework which made a sustainable contribution to reduce the burden of cancer in the EU and towards maintaining the target of a 15% reduction by 2020. According to the last available data, in the period 2000-2010, the incidence of the most frequently occurring forms of cancers (i.e. breast, lung, prostate and colorectal) decreased by about 10%. In order to take forward this cooperation, the Commission sets out some of the next steps: - the 3rd EU Health Programme offers opportunities to promote public health action on cancer and Horizon 2020 , in particular its Health, demographic change and wellbeing objective, offers opportunities to pursue research on cancer and other major chronic diseases. - continued support for the development of high quality National Cancer Plans in the European Union; - the new Tobacco Products Directive which should be fully operational by ensuring full use of its delegated and implementing powers as well as supporting its implementation by Member States in order to reduce smoking throughout the EU and contributing to reduce the incidence of cancer; - enhance cooperation between the fields of Public Health, Environment and Occupational Health in order to tackle the avoidable causes of cancer from a broader perspective; supporting a voluntary European Quality Assurance scheme for breast cancer services; - creation of European Reference Networks, including on rare tumours. The Commission intends to organise calls for Networks in 2014 and 2015; improving screening programmes and networking between centres and experts, at the EU, national and regional level; - consideration of a specific Action on Rare Cancers; - wider uptake of eHealth for efficient disease management and to strengthen effective prevention practices. The recommendations of Members States and stakeholders, in the framework of the Commission Group of Experts on Cancer Control, will also be taken into account. The report states that the Commission maintains the objective of reducing the burden of cancer in the EU, and the target of a 15% reduction of cancer incidence by 2020 ( 510,000 new cases ). type: Follow-up document body: EC
    events
    • date: 2003-05-05T00:00:00 type: Legislative proposal published body: EC docs: url: https://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2003&nu_doc=230 title: EUR-Lex title: COM(2003)0230 summary:
    • date: 2003-09-01T00:00:00 type: Committee referral announced in Parliament, 1st reading/single reading body: EP
    • date: 2003-11-04T00:00:00 type: Vote in committee, 1st reading/single reading body: EP summary:
    • date: 2003-11-04T00:00:00 type: Committee report tabled for plenary, 1st reading/single reading body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A5-2003-381&language=EN title: A5-0381/2003
    • date: 2003-11-18T00:00:00 type: Debate in Parliament body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?secondRef=TOC&language=EN&reference=20031118&type=CRE title: Debate in Parliament
    • date: 2003-11-19T00:00:00 type: Decision by Parliament, 1st reading/single reading body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P5-TA-2003-502 title: T5-0502/2003 summary:
    • date: 2003-12-01T00:00:00 type: Resolution/conclusions adopted by Council body: CSL
    • date: 2003-12-02T00:00:00 type: Act adopted by Council after consultation of Parliament body: EP/CSL
    • date: 2003-12-02T00:00:00 type: End of procedure in Parliament body: EP
    • date: 2003-12-16T00:00:00 type: Final act published in Official Journal
    other
    • body: EC dg: Development
    procedure/dossier_of_the_committee
    Old
    ENVI/5/19574
    New
    • ENVI/5/19574
    procedure/final/title
    Old
    OJ L 327 16.12.2003, p. 0034-0038
    New
    OJ L 327 16.12.2003, p. 0034-0038
    procedure/final/url
    Old
    http://eur-lex.europa.eu/JOHtml.do?uri=OJ:L:2003:327:SOM:EN:HTML
    New
    https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L:2003:327:TOC
    procedure/subject
    Old
    • 4.20.01 Medicine, diseases
    • 4.20.05 Health legislation and policy
    New
    4.20.01
    Medicine, diseases
    4.20.05
    Health legislation and policy
    activities/5/council
    Employment, Social Policy, Health and Consumer Affairs
    activities/5/meeting_id
    2549
    activities/5/type
    Old
    Resolution/conclusions adopted by Council
    New
    Council Meeting
    activities/6
    date
    2003-12-02T00:00:00
    body
    CSL
    type
    Council Meeting
    council
    Employment, Social Policy, Health and Consumer Affairs
    meeting_id
    2549
    links/European Commission/title
    Old
    PreLex
    New
    EUR-Lex
    activities
    • date: 2003-05-05T00:00:00 docs: url: http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2003&nu_doc=230 celexid: CELEX:52003PC0230:EN type: Legislative proposal published title: COM(2003)0230 type: Legislative proposal published body: EC commission: DG: Development
    • date: 2003-09-01T00:00:00 body: EP type: Committee referral announced in Parliament, 1st reading/single reading committees: body: EP responsible: True committee: ENVI date: 2003-07-08T00:00:00 committee_full: Environment, Public Health, Consumer Policy rapporteur: group: UEN name: MUSSA Antonio body: EP responsible: False committee: FEMM date: 2003-05-20T00:00:00 committee_full: Women's Rights and Equal Opportunities rapporteur: group: PSE name: JÖNS Karin body: EP responsible: False committee_full: Industry, External Trade, Research, Energy committee: ITRE
    • body: EP committees: body: EP responsible: True committee: ENVI date: 2003-07-08T00:00:00 committee_full: Environment, Public Health, Consumer Policy rapporteur: group: UEN name: MUSSA Antonio body: EP responsible: False committee: FEMM date: 2003-05-20T00:00:00 committee_full: Women's Rights and Equal Opportunities rapporteur: group: PSE name: JÖNS Karin body: EP responsible: False committee_full: Industry, External Trade, Research, Energy committee: ITRE docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A5-2003-381&language=EN type: Committee report tabled for plenary, 1st reading/single reading title: A5-0381/2003 date: 2003-11-04T00:00:00 type: Vote in committee, 1st reading/single reading
    • date: 2003-11-18T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?secondRef=TOC&language=EN&reference=20031118&type=CRE type: Debate in Parliament title: Debate in Parliament body: EP type: Debate in Parliament
    • date: 2003-11-19T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P5-TA-2003-502 type: Decision by Parliament, 1st reading/single reading title: T5-0502/2003 body: EP type: Decision by Parliament, 1st reading/single reading
    • date: 2003-12-01T00:00:00 body: CSL type: Resolution/conclusions adopted by Council
    • date: 2003-12-02T00:00:00 body: CSL type: Council Meeting council: Employment, Social Policy, Health and Consumer Affairs meeting_id: 2549
    • date: 2003-12-02T00:00:00 body: EP type: End of procedure in Parliament
    • date: 2003-12-02T00:00:00 body: EP/CSL type: Act adopted by Council after consultation of Parliament
    • date: 2003-12-16T00:00:00 type: Final act published in Official Journal
    committees
    • body: EP responsible: True committee: ENVI date: 2003-07-08T00:00:00 committee_full: Environment, Public Health, Consumer Policy rapporteur: group: UEN name: MUSSA Antonio
    • body: EP responsible: False committee: FEMM date: 2003-05-20T00:00:00 committee_full: Women's Rights and Equal Opportunities rapporteur: group: PSE name: JÖNS Karin
    • body: EP responsible: False committee_full: Industry, External Trade, Research, Energy committee: ITRE
    links
    European Commission
    other
    • body: EC dg: Development
    procedure
    dossier_of_the_committee
    ENVI/5/19574
    reference
    2003/0093(CNS)
    instrument
    Recommendation
    legal_basis
    EC Treaty (after Amsterdam) EC 152-p4
    stage_reached
    Procedure completed
    subtype
    Legislation
    title
    Cancer screening
    type
    CNS - Consultation procedure
    final
    subject